Real World Data from Patients With Osteosarcoma Treated in 8 Medical Centers in Greece: Ninety Percent or Greater Tumor Necrosis Is Associated With Disease-free Survival.

Saved in:
Bibliographic Details
Title: Real World Data from Patients With Osteosarcoma Treated in 8 Medical Centers in Greece: Ninety Percent or Greater Tumor Necrosis Is Associated With Disease-free Survival.
Authors: Kyriazoglou A; Medical Oncology Unit, 2nd Propaedeutic Department of Medicine, School of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Moutafi M; Medical Oncology Unit, 2nd Propaedeutic Department of Medicine, School of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Kotsantis I; Medical Oncology Unit, 2nd Propaedeutic Department of Medicine, School of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Kokkali S; First Oncology clinic, Agios Savvas Anticancer Hospital, Athens, Greece.; Oncology Unit, 2nd Department of Internal Medicine, National and Kapodistrian University of Athens, Ippokrateion General Hospital, Athens, Greece., Antonopoulou P; Medical Oncology Unit, 2nd Propaedeutic Department of Medicine, School of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Ardavanis G; First Oncology clinic, Agios Savvas Anticancer Hospital, Athens, Greece., Magkou E; First Oncology clinic, Agios Savvas Anticancer Hospital, Athens, Greece., Georgaki E; Oncology Unit, 2nd Department of Internal Medicine, National and Kapodistrian University of Athens, Ippokrateion General Hospital, Athens, Greece., Anastasiou M; Medical Oncology Unit, 2nd Propaedeutic Department of Medicine, School of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Pantazopoulos A; Medical Oncology Unit, 2nd Propaedeutic Department of Medicine, School of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Boulouta A; Medical Oncology Unit, 2nd Propaedeutic Department of Medicine, School of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Kyrkasiadou M; Medical Oncology Unit, 2nd Propaedeutic Department of Medicine, School of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Gavrielatou N; Medical Oncology Unit, 2nd Propaedeutic Department of Medicine, School of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Zazas E; Medical Oncology Unit, 2nd Propaedeutic Department of Medicine, School of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Economopoulou P; Medical Oncology Unit, 2nd Propaedeutic Department of Medicine, School of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Ardavanis A; First Oncology clinic, Agios Savvas Anticancer Hospital, Athens, Greece., Kontogeorgakos V; Orthopaedic Surgery & Traumatology Department, School of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Lakiotaki E; Department of Pathology, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Korkolopoulou P; Department of Pathology, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Papagelopoulos PJ; Orthopaedic Surgery & Traumatology Department, School of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Psyrri A; Medical Oncology Unit, 2nd Propaedeutic Department of Medicine, School of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Boukovinas I; Department of Medical Oncology, Bioclinic, Thessaloniki, Greece.
Source: Cancer diagnosis & prognosis [Cancer Diagn Progn] 2025 Oct 30; Vol. 5 (6), pp. 833-843. Date of Electronic Publication: 2025 Oct 30 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 9918316186306676 Publication Model: eCollection Cited Medium: Internet ISSN: 2732-7787 (Electronic) Linking ISSN: 27327787 NLM ISO Abbreviation: Cancer Diagn Progn Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2732-7787
DOI:10.21873/cdp.10498